Breakthrough in Cancer Gene Therapy: Nanoparticle Research Sheds Light on Glioma Targeting

Researchers from Fudan University have made a significant discovery in cancer gene therapy, specifically in targeting gliomas. Their study, published in the journal Nanoscale, has shown that modifying the formulation of lipid-based nanoparticles can lead to improved efficacy in delivering therapeutic agents to glioma cells. The research found that by increasing the proportion of polyethylene glycol (PEG), nanoparticles undergo a transition from liposomes to nanodiscs and ultimately to micelles, resulting in enhanced barrier-crossing ability and glioma targeting.

Key Takeaways:

• The study found that by increasing the proportion of PEG, nanoparticles undergo a transition from liposomes to nanodiscs and micelles, which results in improved efficacy in delivering therapeutic agents to glioma cells.
• The researchers discovered that despite being taken up by cells at a higher rate, nanodiscs showed better barrier-crossing ability and glioma targeting than liposomes and micelles.
• The study established specific methods to investigate the behavior of nanodiscs and their glioma targeting ability, demonstrating that nanodiscs have advantages in multiple stages of delivery.
• Among different lipid-based nanoparticles, nanodiscs are shown to be promising for clinical translation, with a formulation similar to liposomes but superior performance.
• The research concluded that the methods established in this study can be instructive for further understanding nanomedicines and their applications.

Statistics:

• The study was supported by the National Natural Science Foundation of China.
• The research team included 17 authors from Fudan University and the State Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers.
• The study was published in the journal Nanoscale, which is published by the Royal Society of Chemistry.
• The research aims to provide insights into the behavior and efficacy of nanodiscs in glioma targeting, with potential applications in clinical translation.

Sources:

• Quantitative to qualitative transition: comparison of in vitro and in vivo behavior and glioma-targeted delivery of PEGylated lipid-based nanoparticles. Nanoscale, 2025.
• NewsRx. Fudan University Reports Findings in Cancer Gene Therapy (Quantitative to qualitative transition: comparison of in vitro and in vivo behavior and glioma-targeted delivery of PEGylated lipid-based nanoparticles). Nanotechnology Weekly. July 28, 2025; p 356.